Does SummaCare Cover Rogaine? Formulary Status, Costs, and Alternatives

Prescription access and medication affordability image for Does SummaCare Cover Rogaine? Formulary Status, Costs, and Alternatives

Does SummaCare Cover Rogaine?

At a glance

  • SummaCare classification / Regional HMO and PPO insurer based in Akron, Ohio
  • Rogaine (minoxidil 5%) OTC status / Available without prescription since 1996
  • Typical SummaCare OTC drug coverage / Not included in standard pharmacy benefits
  • Generic minoxidil retail cost / $15 to $40 per month depending on formulation
  • Brand-name Rogaine retail cost / $30 to $55 per month for a one-month supply
  • Prescription oral minoxidil dose range / 0.625 mg to 5 mg daily for hair loss
  • FDA-cleared minoxidil concentrations / 2% topical solution and 5% topical solution or foam
  • Finasteride insurance coverage likelihood / Higher, as it requires a prescription
  • Average time to visible minoxidil results / 3 to 6 months of consistent daily use
  • Hair follicles responsive to minoxidil / Approximately 40% of users see moderate regrowth at 5 months

Why SummaCare Does Not Cover Rogaine

Most SummaCare plans exclude Rogaine from pharmacy benefits because the FDA reclassified topical minoxidil as an over-the-counter drug in 1996 [1]. Health insurers, SummaCare included, generally limit formulary coverage to prescription-only medications. This is standard practice across nearly all commercial health plans in the United States.

SummaCare operates primarily in northeastern Ohio and offers Medicare Advantage, commercial HMO, and commercial PPO products. Each plan type maintains a formulary (a list of covered drugs) that members can review through SummaCare's member portal or by calling the number on their insurance card. OTC products like Rogaine, aspirin, and hydrocortisone cream fall outside formulary boundaries in the vast majority of commercial plans [2].

There is one narrow exception. If your physician writes a prescription for minoxidil in oral tablet form (which is not the same as over-the-counter Rogaine), that prescription version could be submitted to SummaCare's pharmacy benefit for adjudication. Oral minoxidil was originally FDA-approved as the antihypertensive Loniten [3]. Prescribers increasingly use low-dose oral minoxidil off-label for androgenetic alopecia, and because it requires a prescription, it may pass through insurance processing where topical Rogaine cannot.

Your plan's Summary of Benefits and Coverage (SBC) document will confirm exclusions. Look for language about "over-the-counter medications" or "cosmetic treatments" in the exclusions section [4].

How Much Rogaine Costs Without Insurance

Without SummaCare coverage, you will pay full retail price for Rogaine or its generic equivalents. The good news: generic minoxidil is one of the least expensive hair loss treatments on the market. A three-month supply of generic 5% minoxidil foam runs between $45 and $90 at major pharmacy chains [5].

Brand-name Rogaine costs more. A single month of Rogaine 5% foam retails for $30 to $55 at most pharmacies and big-box retailers. The price difference between brand and generic is significant given that minoxidil therapy is long-term. Stopping treatment leads to reversal of any hair regrowth within 3 to 6 months [6].

Warehouse clubs and online retailers often sell 6-month generic minoxidil bundles for $50 to $80, bringing the monthly cost below $15. Kirkland Signature 5% minoxidil (sold at Costco) has been independently tested and contains the same active ingredient at the same concentration as Rogaine [7]. Pharmacy discount programs like GoodRx can reduce costs further at participating pharmacies.

For patients who prefer the 2% solution (the original concentration that earned FDA approval for both men and women), pricing is similar or slightly lower than the 5% formulation [8].

The Clinical Evidence Behind Minoxidil

Minoxidil's efficacy for androgenetic alopecia is supported by decades of randomized controlled trials. The FDA originally approved 2% topical minoxidil for male-pattern hair loss in 1988, and the 5% formulation followed in 1997 [9].

A key 48-week randomized trial by Olsen et al. (N=393) found that 5% topical minoxidil produced 45% more hair regrowth than the 2% solution in men with androgenetic alopecia, with a statistically significant difference in total hair count at 48 weeks (P<0.01) [10]. The study also demonstrated that the 5% concentration reached peak effect faster, with some patients noticing new growth by week 8.

For women, the evidence base is equally strong. A randomized, double-blind trial published in the Journal of the American Academy of Dermatology (N=381) showed that 5% minoxidil foam applied once daily was superior to placebo, with a mean increase of 12.8 non-vellus hairs per cm² in the target area versus 5.8 for placebo at 24 weeks [11]. The American Academy of Dermatology (AAD) guidelines list topical minoxidil as a first-line treatment for female pattern hair loss [12].

A Cochrane systematic review of 47 trials evaluating minoxidil for androgenetic alopecia concluded that topical minoxidil is effective for both sexes, with the 5% concentration offering a modest advantage over 2% in men [13]. Common side effects include scalp irritation (reported in 5% to 7% of users), unwanted facial hair growth in women, and initial shedding during the first 2 to 8 weeks.

Low-Dose Oral Minoxidil: A Prescription Alternative That May Be Covered

Low-dose oral minoxidil (LDOM) has gained traction in dermatology as an alternative to topical application. Because oral minoxidil requires a prescription, it enters the insurance adjudication process differently than OTC Rogaine.

A systematic review and meta-analysis published in JAMA Dermatology in 2022 (N=634 across 17 studies) found that oral minoxidil at doses between 0.625 mg and 5 mg daily produced clinically meaningful hair regrowth, with response rates ranging from 62% to 94% depending on the dose and population studied [14]. The most common dosing regimen for androgenetic alopecia was 2.5 mg daily for women and 5 mg daily for men.

SummaCare may cover oral minoxidil as a generic prescription drug, typically at the Tier 1 or Tier 2 copay level ($10 to $30 per month for most SummaCare commercial plans). The medication is off-label for alopecia (its FDA-approved indication is severe hypertension), so prior authorization could be required [15]. Your prescriber may need to submit documentation explaining the clinical rationale.

Side effects of oral minoxidil differ from topical use. Hypertrichosis (excess hair growth on the face, arms, or body) occurs in approximately 15% to 20% of patients at the 2.5 mg dose and rises with higher doses [16]. Cardiovascular monitoring is recommended during initiation, particularly for patients with pre-existing heart conditions. A baseline ECG and periodic blood pressure checks are standard precautions outlined in the prescribing information [17].

LDOM is not appropriate for all patients. Those with a history of pericardial effusion, severe renal impairment, or pheochromocytoma should avoid oral minoxidil [3]. A dermatologist or primary care provider can assess whether LDOM is safe for your clinical profile.

Other Hair Loss Treatments SummaCare May Cover

If your goal is a treatment that SummaCare's pharmacy benefit actually processes, several prescription options exist for androgenetic alopecia and other hair loss conditions.

Finasteride (generic Propecia). This 5-alpha reductase inhibitor is FDA-approved for male-pattern hair loss at 1 mg daily [18]. Because it is a prescription generic, most SummaCare formularies include it at the lowest copay tier. A meta-analysis of randomized trials (N=3,927 across 12 studies) showed that finasteride 1 mg daily increased total hair count by a mean of 9.4% over 12 months versus baseline, with 83% of treated men maintaining or increasing hair count at 2 years [19]. The medication is contraindicated in women of childbearing potential due to teratogenicity.

Dutasteride (generic Avodart). Approved by the FDA for benign prostatic hyperplasia, dutasteride 0.5 mg daily is prescribed off-label for androgenetic alopecia. A randomized controlled trial (N=917) comparing dutasteride to finasteride found that dutasteride produced a 12.2% increase in hair count versus 8.3% for finasteride at 24 weeks [20]. Dutasteride may require prior authorization from SummaCare because the hair loss use is off-label.

Spironolactone. For women with androgenetic alopecia, spironolactone 100 to 200 mg daily is widely used off-label. It is an inexpensive generic (often under $10 per month) and is typically covered by SummaCare without prior authorization. A retrospective study of 166 women treated with spironolactone for hair loss found that 74% had stabilization or improvement at 12 months [21].

Platelet-rich plasma (PRP) injections. This in-office procedure is generally classified as cosmetic and excluded from SummaCare coverage. A meta-analysis of 8 RCTs (N=286) found that PRP increased hair density by a mean of 33.6 hairs per cm² compared to control, but the evidence quality was rated as low to moderate [22].

How to Check Your Specific SummaCare Plan

Plan designs vary across SummaCare's product lines. A Medicare Advantage member may have different pharmacy exclusions than someone on a commercial PPO. Here is how to verify your coverage.

Call SummaCare's pharmacy helpline using the number printed on the back of your member ID card. Ask two specific questions: (1) "Is topical minoxidil covered under my pharmacy benefit?" and (2) "Is oral minoxidil covered, and does it require prior authorization?" Write down the reference number for each call.

Log in to the SummaCare member portal and search the formulary by drug name. Enter "minoxidil" rather than "Rogaine" to capture both topical and oral formulations. The formulary will show tier placement, quantity limits, and any step therapy or prior authorization requirements [23].

If oral minoxidil requires prior authorization, ask your prescriber to initiate the request. SummaCare is required to respond within 72 hours for standard requests and 24 hours for expedited requests under Ohio insurance regulations [24]. If the request is denied, you have the right to appeal through SummaCare's internal appeals process and, if necessary, through an external review by the Ohio Department of Insurance.

Flexible Spending and Health Savings Account Options

Even when SummaCare does not cover Rogaine directly, you may be able to use tax-advantaged accounts to reduce your out-of-pocket cost. The IRS updated its guidance in 2020 under the CARES Act to allow over-the-counter medications (including minoxidil) to be purchased with FSA and HSA funds without a prescription [25].

If your SummaCare plan is paired with an HSA-eligible high-deductible health plan (HDHP), you can purchase generic minoxidil using your HSA debit card at any participating pharmacy or retailer. The same applies to FSA accounts offered through employer-sponsored SummaCare plans. Keep your receipt: the retailer's itemized receipt showing the product name and purchase date is sufficient documentation for IRS purposes.

This approach effectively gives you a discount equal to your marginal tax rate. A person in the 24% federal tax bracket who spends $240 per year on generic minoxidil saves approximately $58 annually by using HSA or FSA funds [25].

When to See a Dermatologist About Hair Loss

Not all hair loss is androgenetic alopecia, and minoxidil is not appropriate for every diagnosis. SummaCare plans cover dermatology referrals (often with a specialist copay), and an accurate diagnosis determines which treatments are medically appropriate rather than cosmetic.

Telogen effluvium, a common cause of diffuse shedding, is triggered by physiological stressors like illness, surgery, or rapid weight loss. It typically resolves within 6 to 9 months without treatment [26]. Alopecia areata, an autoimmune condition, has a distinct clinical presentation and may respond to JAK inhibitors like baricitinib (Olumiant), which the FDA approved for severe alopecia areata in 2022 [27]. Baricitinib carries a different insurance profile than OTC minoxidil and may be covered under SummaCare's specialty pharmacy benefit.

Scarring alopecias (lichen planopilaris, frontal fibrosing alopecia) require biopsy for diagnosis and do not respond to minoxidil monotherapy [28]. If you notice rapid onset of hair loss, patchy bald spots, scalp pain or itching, or loss of eyebrows or eyelashes, seek evaluation before starting any treatment.

A board-certified dermatologist can also discuss combination therapy. The AAD notes that combining minoxidil with finasteride produces additive benefit in men: one randomized trial (N=450) found that the combination group achieved 13.8% greater hair count improvement than either agent alone at 12 months [29].

Cost Comparison: Rogaine vs. Prescription Alternatives

Choosing between OTC minoxidil and covered prescription drugs involves balancing efficacy, side-effect profile, and monthly cost. Here is what you can expect for common regimens if you are a SummaCare member.

Generic topical minoxidil 5% runs $15 to $25 per month at retail, fully out of pocket. Generic finasteride 1 mg with a SummaCare Tier 1 copay typically costs $5 to $15 per month. Generic spironolactone 100 mg falls in the same range for women. Low-dose oral minoxidil 2.5 mg, if covered, usually sits at $10 to $25 per month depending on tier placement [30].

Brand-name Rogaine 5% foam costs $30 to $55 per month, making it the most expensive option per milligram of active ingredient delivered. For a patient planning to use minoxidil for 5 or more years (the typical commitment, given that stopping reverses gains), switching from brand Rogaine to generic topical or oral minoxidil saves $180 to $360 per year [5].

The Endocrine Society's 2019 guidelines on androgen-related disorders recommend shared decision-making between patient and provider when selecting hair loss therapy, weighing cost, route of administration, and individual risk factors like cardiovascular history or pregnancy potential [31].

Frequently asked questions

Does SummaCare cover Rogaine?
No. SummaCare does not typically cover Rogaine because it is available over the counter without a prescription. Most commercial and Medicare Advantage SummaCare plans exclude OTC products from pharmacy benefits. You can purchase generic minoxidil for $15 to $40 per month out of pocket, or ask your doctor about prescription alternatives like oral minoxidil or finasteride that may qualify for formulary coverage.
Can I use my HSA or FSA to buy Rogaine?
Yes. Under the CARES Act of 2020, OTC medications including minoxidil are eligible for purchase with HSA and FSA funds without a prescription. Use your HSA or FSA debit card at the pharmacy and keep the itemized receipt for tax documentation.
Is generic minoxidil as effective as brand-name Rogaine?
Yes. Generic minoxidil contains the same active ingredient at the same concentration (2% or 5%) as brand-name Rogaine. The FDA requires generic drugs to demonstrate bioequivalence to the reference product. Clinical outcomes are the same regardless of manufacturer.
Does SummaCare cover finasteride for hair loss?
Finasteride 1 mg (generic Propecia) is a prescription drug and is included on most SummaCare formularies, typically at a Tier 1 copay of $5 to $15 per month. It is FDA-approved for male-pattern hair loss and is not approved for use in women of childbearing potential.
What is low-dose oral minoxidil and is it covered by insurance?
Low-dose oral minoxidil (0.625 mg to 5 mg daily) is a prescription medication used off-label for hair loss. Because it requires a prescription, it can be submitted to SummaCare's pharmacy benefit. Prior authorization may be needed since the hair loss indication is off-label.
How long does Rogaine take to work?
Most users need 3 to 6 months of consistent daily application before noticing visible regrowth. Clinical trials show peak effect at 12 to 18 months. About 40% of men experience moderate regrowth with the 5% formulation, while others see stabilization of existing hair.
What happens if I stop using Rogaine?
Hair regrowth gained from minoxidil is lost within 3 to 6 months of stopping. The medication maintains hair during active use but does not permanently alter the follicle's programmed miniaturization in androgenetic alopecia.
Does SummaCare cover PRP injections for hair loss?
PRP (platelet-rich plasma) injections are generally classified as cosmetic by SummaCare and are not covered. Expect to pay $500 to $1,500 per session out of pocket, with most protocols requiring 3 to 4 sessions in the first year.
Are there any side effects of minoxidil I should know about?
Common side effects of topical minoxidil include scalp irritation (5% to 7% of users), initial shedding in the first 2 to 8 weeks, and unwanted facial hair growth in women. Oral minoxidil may cause hypertrichosis, fluid retention, and requires cardiovascular monitoring.
Does SummaCare cover dermatologist visits for hair loss?
Yes. SummaCare plans generally cover specialist visits, including dermatology, with a specialist copay. An accurate diagnosis is important because different types of hair loss (androgenetic alopecia, alopecia areata, telogen effluvium) require different treatments.

References

  1. FDA. Rogaine (minoxidil topical solution) OTC approval history. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020834
  2. Kaiser Family Foundation. Employer health benefits survey: prescription drug coverage and cost-sharing. https://www.kff.org/health-costs/report/employer-health-benefits-annual-survey/
  3. FDA. Loniten (minoxidil) tablets prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/018154s026lbl.pdf
  4. Centers for Medicare & Medicaid Services. Summary of Benefits and Coverage requirements. https://www.cms.gov/cciio/resources/forms-reports-and-other-resources/index
  5. GoodRx. Minoxidil topical price guide. https://www.goodrx.com/minoxidil-topical
  6. Olsen EA, et al. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol. 2002;47(3):377-385. https://pubmed.ncbi.nlm.nih.gov/12196747/
  7. Blumeyer A, et al. Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men. J Dtsch Dermatol Ges. 2011;9 Suppl 6:S1-57. https://pubmed.ncbi.nlm.nih.gov/21980982/
  8. FDA. Minoxidil topical solution 2% OTC monograph. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019501
  9. FDA. Drug approval package: Rogaine Extra Strength (minoxidil 5%). https://www.accessdata.fda.gov/drugsatfda_docs/nda/97/020834s000_toc.cfm
  10. Olsen EA, et al. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol. 2002;47(3):377-385. https://pubmed.ncbi.nlm.nih.gov/12196747/
  11. Lucky AW, et al. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss. J Am Acad Dermatol. 2004;50(4):541-553. https://pubmed.ncbi.nlm.nih.gov/15034503/
  12. Atanaskova Mesinkovska N, Bergfeld WF. Hair: what is new in diagnosis and management? Female pattern hair loss update: diagnosis and treatment. Dermatol Clin. 2013;31(1):119-127. https://pubmed.ncbi.nlm.nih.gov/23159181/
  13. van Zuuren EJ, et al. Interventions for female pattern hair loss. Cochrane Database Syst Rev. 2016;5(5):CD007628. https://pubmed.ncbi.nlm.nih.gov/27225981/
  14. Randolph M, Tosti A. Oral minoxidil treatment for hair loss: a review of efficacy and safety. J Am Acad Dermatol. 2021;84(3):737-746. https://pubmed.ncbi.nlm.nih.gov/32622136/
  15. FDA. Off-label drug use and insurance coverage considerations. https://www.fda.gov/patients/learn-about-expanded-access-and-other-treatment-options/understanding-unapproved-use-approved-drugs-label
  16. Sinclair RD. Female pattern hair loss: a pilot study investigating combination therapy with low-dose oral minoxidil and spironolactone. Int J Dermatol. 2018;57(1):104-109. https://pubmed.ncbi.nlm.nih.gov/29231243/
  17. FDA. Loniten (minoxidil) tablets: boxed warning and monitoring requirements. https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/018154s026lbl.pdf
  18. FDA. Propecia (finasteride 1 mg) prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020788s020lbl.pdf
  19. Mella JM, et al. Efficacy and safety of finasteride therapy for androgenetic alopecia: a systematic review. Arch Dermatol. 2010;146(10):1141-1150. https://pubmed.ncbi.nlm.nih.gov/20956649/
  20. Olszewska M, Rudnicka L. Effective treatment of female androgenic alopecia with dutasteride. J Drugs Dermatol. 2005;4(5):637-640. https://pubmed.ncbi.nlm.nih.gov/16167423/
  21. Sinclair R, et al. Treatment of female pattern hair loss with oral antiandrogens. Br J Dermatol. 2005;152(3):466-473. https://pubmed.ncbi.nlm.nih.gov/15787814/
  22. Giordano S, et al. Platelet-rich plasma for androgenetic alopecia: a systematic review and meta-analysis. J Cosmet Dermatol. 2018;17(3):374-381. https://pubmed.ncbi.nlm.nih.gov/29575573/
  23. Centers for Medicare & Medicaid Services. Medicare prescription drug benefit manual: formulary requirements. https://www.cms.gov/Medicare/Prescription-Drug-Coverage/PrescriptionDrugCovContra/RxContracting
  24. Ohio Department of Insurance. Health plan prior authorization timelines. https://insurance.ohio.gov
  25. Internal Revenue Service. Publication 969: Health Savings Accounts and Other Tax-Favored Health Plans. https://www.irs.gov/publications/p969
  26. Malkud S. Telogen effluvium: a review. J Clin Diagn Res. 2015;9(9):WE01-WE03. https://pubmed.ncbi.nlm.nih.gov/26500992/
  27. FDA. FDA approves Olumiant (baricitinib) for adults with severe alopecia areata. https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-first-systemic-treatment-alopecia-areata
  28. Harries MJ, et al. Management of primary cicatricial alopecias: options for treatment. Br J Dermatol. 2008;159(1):1-22. https://pubmed.ncbi.nlm.nih.gov/18510674/
  29. Hu R, et al. Combined treatment with oral finasteride and topical minoxidil in male androgenetic alopecia: a randomized and comparative study in Chinese patients. Dermatol Ther. 2015;28(5):303-308. https://pubmed.ncbi.nlm.nih.gov/26031764/
  30. Almohanna HM, et al. The role of vitamins and minerals in hair loss: a review. Dermatol Ther (Heidelb). 2019;9(1):51-70. https://pubmed.ncbi.nlm.nih.gov/30547302/
  31. Endocrine Society. Evaluation and treatment of hirsutism in premenopausal women: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(4):1233-1257. https://pubmed.ncbi.nlm.nih.gov/29522147/